Nevirapine-induced cutaneous hypersensitivity reactions and successful tolerance induction.
Demoly
P
P
Department of Maladies Respiratoires, Institut National de la Santé et de la Recherche Médicale U454-IFR3, Hôpital Arnaud de Villeneuve, and Centre Hospitalier Universitaire, Montpellier, France.
Messaad
D
D
Fabre
J
J
Reynes
J
J
Bousquet
J
J
D000328:Adult; D004361:Drug Tolerance / Q000276:immunology; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D008297:Male; D019829:Nevirapine / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D012882:Skin Tests; D014581:Urticaria / Q000139:chemically induced*
D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine